Faculty

Institution

Unit

Venue

Brittney H. Cotta

Assistant Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Palliative, Rehabilitation And Integrative Medicine

Department Of Neurosurgery

Division Of Surgery

Department Of Urology

Department Of Neurosurgery

Division Of Surgery

The University of Texas MD Anderson Cancer Center

Brittney H. Cotta is currently serving as a Neurosurgery Assistant Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Brittney H. Cotta

The University of Texas MD Anderson Cancer Center

Assistant Professor

You can click a keyword to filter the displayed items

urology oncology genitourinary cancers surgical oncology cancer research kidney cancer cancer care neurology surgery nephrology survival analysis renal cell carcinoma medicinal research metastasis cancer cells cancer genomics prognosis health sciences thoracic oncology renal function cancer biology cancer imaging cancer disparities cancer immunosurveillance partial nephrectomy clinical proteomics jama oncology molecular cancer cancer management kidney research cancer treatment chronic kidney disease reconstructive microsurgery clinical evidence renal pathophysiology renal cancer international marker consortium genomics respiratory medicine clinical transplantation prognostic biomarkers treatment and prevention hematological malignancies comparative analysis clinical radiation oncology reconstructive urology opioid use disorder risk factors thrombosis leukemia histopathology cell research systemic therapy postoperative pain management perioperative pain graft survival randomized controlled trials renal care kidney transplantation cancer growth immunoediting lumen-apposing metal stent voiding dysfunction opioid epidemic acute kidney injury current landscape genomic biomarkers future perspectives current state multicenter comparative analysis neoadjuvant sunitinib thrombus size advanced renal cancer international analysis inpatient narcotic requirements penile prosthesis implantation translational research gynecologic oncology pathology prostate cancer translational medicine cell biology medicine clinical biochemistry molecular diagnostics breast cancer tumor microenvironment urogynecology biomarkers bladder cancer therapeutic targets cancer immunotherapy sarcoma surgical pathology lung cancer cancer letter tumor biology carcinogenesis biomedical informatics radiation oncology systems biology brain tumor research cancer discovery mesothelioma oncogenes experimental medicine molecular medicine

Notable Scholarly Works

Notable Federal Grants

Collaborators

Beyond Clear Cell: Rethinking Postoperative Surveillance for Non-Clear Cell Renal Cell Carcinoma Subtypes. European Urology Oncology (2026)

pathologyurologykidney cancersurgical pathologygenitourinary cancerscancer researchoncologysurgical oncologymetastasiskidney researchclear cellpostoperative surveillanceurological research

Ip59-15 Postoperative Surveillance in Non-Clear Cell Renal Cancer: Is Current Practice Best Practice?. The Journal of Urology (2026)

urologypathologykidney cancersurgical pathologycancer researchoncologycancer lettercancer discoverysurgical oncologyradiation oncologymetastasisthoracic oncologybladder cancercancer carechronic kidney diseasenephrologyjama oncology

Ip81-17 Persistent Gender Disparities in Urologic Oncology: Trends in Urology Residency and Urologic Oncology Fellowship Match Among Female Trainees. The Journal of Urology (2026)

urologytransgender healthkidney cancergender identityprostate canceroncologysurgical oncologyurogynecologysex rolesbladder cancergender inequalitygender studiesgynecologic oncologycancer caregynecologygender diversitywomen's health

Molecular Profiling of Primary Versus Paired Asynchronous Metastatic Clear Cell Renal Cell Carcinoma Reveals Heterogeneity in Tumor Immune Microenvironment. Scientific Reports (2026)

urologykidney cancertumor immune microenvironmentcancer cellsgenitourinary cancerstumor microenvironmentmolecular profilingtumor heterogeneitymetastasisprimary versustumor biologycancer immunosurveillancecell biologymolecular diagnostics

Postoperative Surveillance in Non Clear Cell Renal Cancer: Is Current Practice Best Practice?. Journal of Clinical Oncology (2026)

urologykidney cancergenitourinary cancersoncologysurgical oncologykidney failurecancer caresurgerypostoperative surveillance

Patient-Derived Renal Cell Cancer Organoids as a Model to Assess Therapeutic Targets and Treatment Resistance Mechanisms. Urologic Oncology Seminars and Original Investigations (2025)

Daniel A TrinerTrinh M. PhamZayne KnuthSrinivas NallandhighalSteven MondaSophia AbusamraSaravana M. DhanasekaranAaron M. UdagerBrittney CottaFengyun SuHamadi MadhiHiroshi KikuchiSydney TranJiayi TianNathanael HailAlice SemerjianKhaled Z. HafezUdit SinghalSamuel D. KaffenbergerSunitha NagrathArul M. ChinnaiyanEvan T. KellerAllison MayTodd M. MorganAlexander ZaslavskyGanesh S. PalapattuUlka VaishampayanNathan M. MerrillSimpa S. Salami

urologykidney cancercancer treatmenttreatment resistance mechanismsoncology

Postoperative Surveillance Protocols for Renal Cell Carcinoma. (2025)

urologykidney cancergenitourinary cancersoncologysurgical oncologynephrologycancer carerenal cell carcinoma

Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete Metastasectomy. The Journal of Urology (2025)

urologykidney cancergenitourinary cancersoncologyrisk factorsfirst-year recurrencesurgical oncologymetastasiscomplete metastasectomynephrologycancer caresurgery

Surgical Approaches Following Durable Responses to Immunotherapy. Kidney Cancer (2025)

cancer immunotherapyreconstructive microsurgerydurable responsestherapeutic vaccinesimmunomodulationimmunosuppressionimmunotherapyimmunologyimmune responsessurgery

Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell Carcinoma. JCO Precision Oncology (2024)

Rohit MehraSrinivas NallandhighalBrittney CottaZayne KnuthFengyun SuAmy KasputisYuping ZhangRui WangXuhong CaoAaron M. UdagerSaravana M. DhanasekaranMarcin P. CieslikTodd M. MorganSimpa S. Salami

geneticsurologyhealth sciencesgenitourinary cancerscancer researchoncologycancer genomicscancer discoverycancer geneticspersonalized medicineprognosisverificationnephrologycancer risk

1
2
3
4
5
6
7
10 / page

Brittney H. Cotta

Assistant Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Palliative, Rehabilitation And Integrative Medicine

Department Of Neurosurgery

Division Of Surgery

Department Of Urology

Department Of Neurosurgery

Division Of Surgery

The University of Texas MD Anderson Cancer Center

Brittney H. Cotta is currently serving as a Neurosurgery Assistant Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Brittney H. Cotta

The University of Texas MD Anderson Cancer Center

Assistant Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Beyond Clear Cell: Rethinking Postoperative Surveillance for Non-Clear Cell Renal Cell Carcinoma Subtypes. European Urology Oncology (2026)

pathologyurologykidney cancersurgical pathologygenitourinary cancerscancer researchoncologysurgical oncologymetastasiskidney researchclear cellpostoperative surveillanceurological research

Ip59-15 Postoperative Surveillance in Non-Clear Cell Renal Cancer: Is Current Practice Best Practice?. The Journal of Urology (2026)

Ip81-17 Persistent Gender Disparities in Urologic Oncology: Trends in Urology Residency and Urologic Oncology Fellowship Match Among Female Trainees. The Journal of Urology (2026)

Molecular Profiling of Primary Versus Paired Asynchronous Metastatic Clear Cell Renal Cell Carcinoma Reveals Heterogeneity in Tumor Immune Microenvironment. Scientific Reports (2026)

Postoperative Surveillance in Non Clear Cell Renal Cancer: Is Current Practice Best Practice?. Journal of Clinical Oncology (2026)

urologykidney cancergenitourinary cancersoncologysurgical oncologykidney failurecancer caresurgerypostoperative surveillance

Patient-Derived Renal Cell Cancer Organoids as a Model to Assess Therapeutic Targets and Treatment Resistance Mechanisms. Urologic Oncology Seminars and Original Investigations (2025)

urologykidney cancercancer treatmenttreatment resistance mechanismsoncology

Postoperative Surveillance Protocols for Renal Cell Carcinoma. (2025)

urologykidney cancergenitourinary cancersoncologysurgical oncologynephrologycancer carerenal cell carcinoma

Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete Metastasectomy. The Journal of Urology (2025)

urologykidney cancergenitourinary cancersoncologyrisk factorsfirst-year recurrencesurgical oncologymetastasiscomplete metastasectomynephrologycancer caresurgery

Surgical Approaches Following Durable Responses to Immunotherapy. Kidney Cancer (2025)

cancer immunotherapyreconstructive microsurgerydurable responsestherapeutic vaccinesimmunomodulationimmunosuppressionimmunotherapyimmunologyimmune responsessurgery

Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell Carcinoma. JCO Precision Oncology (2024)

Rohit MehraSrinivas NallandhighalBrittney CottaZayne KnuthFengyun SuAmy KasputisYuping ZhangRui WangXuhong CaoAaron M. UdagerSaravana M. DhanasekaranMarcin P. CieslikTodd M. MorganSimpa S. Salami

geneticsurologyhealth sciencesgenitourinary cancerscancer researchoncologycancer genomicscancer discoverycancer geneticspersonalized medicineprognosisverificationnephrologycancer risk

1
2
3
4
5
6
7
10 / page